Arrowstreet Capital’s Upstream Bio UPB Stock Holding History
Bought
Maintained
Sold
Other funds holding UPB
Arrowstreet Capital's UPB Position: Q3 2026 in Review
Arrowstreet Capital reduced its Upstream Bio (UPB) stake by 47% in Q3 2026, selling an estimated $1.1M and leaving 189,832 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #1557.
Arrowstreet Capital first reported a position in UPB in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.48M in Q2 2026. 133 funds tracked by Wall St. Rank hold UPB as of Q3 2026.
- Arrowstreet Capital held 189,832 shares of Upstream Bio worth $1M as of Q3 2026.
- Arrowstreet Capital sold 167,924 Upstream Bio shares in Q3 2026, an estimated $1.1M.
- Upstream Bio made up ﹤0.01% of Arrowstreet Capital's portfolio in Q3 2026, its #1557 holding.
- Arrowstreet Capital first reported a position in Upstream Bio in Q1 2026 and has held it in 3 quarters since.
- Arrowstreet Capital's Upstream Bio position peaked at $2.48M in Q2 2026.
- 133 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.
Based on Arrowstreet Capital's 13F filing for Q3 2026, filed 13 Nov 2026.